Cat Allergy Shots for Humans: The 100-Visit Math and the At-Home Option
Cat allergy shots for humans are subcutaneous immunotherapy (SCIT) for PEOPLE who are allergic to cat dander. They are NOT veterinary products. Cytopoint, Apoquel, and veterinary allergen-specific immunotherapy are for the pet. The plural 'shots' is accurate — conventional SCIT means approximately 95–119 in-clinic visits over 3–5 years, though Curex now delivers the same immunotherapy as a self-administered weekly shot at home.
7 peer-reviewed sources
Cat allergy shots for humans are SCIT for people sensitized to Fel d 1. Conventional in-clinic SCIT requires approximately 95–119 visits over 3–5 years, and 23.9% of patients never complete treatment. Curex now delivers that same SCIT as an at-home weekly shot for $129/month.
The essentials
Cat allergy shots for humans are subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT) for PEOPLE who are allergic to cat dander. They are NOT veterinary products. If you arrived here because you searched 'cat allergy shots' and got information about Cytopoint, Apoquel, or veterinary allergen-specific immunotherapy — those are products injected into the pet (and Cytopoint/Apoquel are dog products, not cat). Feline atopic dermatitis in a cat is managed by a veterinarian, not an allergist. This page covers subcutaneous and sublingual immunotherapy for human patients with cat-dander sensitization.
The plural 'shots' in this search query is clinically accurate — and that is the central message of this page. For humans, cat allergy immunotherapy is not one shot but many. Conventional SCIT per the Cox L et al. JACI 2011 Practice Parameter Third Update requires approximately 26–28 weekly build-up injections plus approximately 13 early-maintenance visits in Year 1 — totaling roughly 39 in-clinic visits in Year 1 alone. Years 2–5 maintenance requires approximately 14–20 visits/year, every 2–4 weeks. The total over a standard 3-to-5-year course is approximately 95–119 in-clinic visits, each with a mandatory 30-minute post-injection observation period.
Tkacz JP et al. (Curr Med Res Opin 2021;37[6]:957–965; IBM MarketScan 2014–2017, n=103,207) found the honest abandonment reality: 23.9% of allergen-immunotherapy patients never returned for the first injection after the index consultation. Only 43.9% ever reached maintenance. This is not a SCIT failure at the mechanistic level — the immune mechanism works. It is a visit-burden failure.
For human cat allergy specifically, this is the one pet allergen where the at-home SLIT alternative has DBPC RCT support. Alvarez-Cuesta E et al. (Allergy 2007;62:810–817) showed 59% reduction in symptom scores versus placebo with no systemic reactions. This makes SLIT drops a genuine evidence-based alternative for human patients who cannot accept the conventional ~100-visit burden. Curex pairs at-home IgE testing with allergist review for Fel d 1, Fel d 2, Fel d 4, and Fel d 7 — distinguishing primary cat-specific sensitization from lipocalin cross-reactivity originating in horse (Fel d 4 ↔ Equ c 1, 67% identity) or dog (Fel d 4 ↔ Can f 6, 67% identity), which can redirect the immunotherapy plan entirely.
On the evidence side: cat-hair and cat-pelt are the only FDA-standardized mammalian allergen extracts in the US (both 10,000 BAU/mL, Greer license #308). Alvarez-Cuesta 1994 JACI (28-patient DBPC; significant improvements vs placebo) and Varney 1997 Clin Exp Allergy (28-patient DBPC; ~72% symptom reduction on natural cat-room challenge) are the foundational trials. The standardized extract and strong RCT base mean cat SCIT has a predictability advantage over dog SCIT that dog-allergic patients do not have access to.
How allergy shots retrain your immune system
Human cat SCIT and SLIT work by inducing immune tolerance to Fel d 1 through repeated controlled exposure, shifting the IgE-mediated allergic response toward IgG4 blocking antibodies and T-regulatory cell tolerance. The biological mechanism requires years — not a single dose — because immune retraining involves sustained allergen-specific T-cell and B-cell reprogramming.
Component-Resolved Diagnosis
Testing Fel d 1 (cat-specific), Fel d 4 (lipocalin), Fel d 7 (lipocalin) before committing identifies whether cat SCIT is targeting the right allergen or whether cross-reactive horse/dog lipocalin sensitization is the primary driver.
Build-Up (~26 weekly visits)
Weekly escalating doses from a starting fraction to the therapeutic maintenance level. A mandatory 30-minute post-injection observation period at every SCIT visit.
Maintenance (every 2–4 weeks, 3–5 years)
Sustained dosing at the therapeutic level induces progressive immune remodeling. The minimum 3-year duration is required for durable post-treatment benefit per Cox 2011 PP3.
Post-Treatment Remission
Durham 1999 NEJM: at least 4-year remission after 3-year SCIT. Estimated 7–12-year benefit after a complete course. This durable remission is the key clinical advantage over indefinite pharmacotherapy.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The 'shots' (plural) in this search term reflects the full reality of cat SCIT for humans: approximately 95–119 in-clinic visits over 3–5 years. Year 1 is the most intensive phase at approximately 39 visits.
Weekly escalating in-clinic injections with mandatory 30-minute observation per visit. Year 1 total (build-up + early maintenance): approximately 39 visits.
Years 2–5: approximately 14–20 in-clinic visits/year. Total course: approximately 95–119 visits. Each visit requires a 30-minute post-injection observation.
After a complete 3-to-5-year course, immune tolerance persists. Durham 1999 NEJM established at least 4-year remission following 3-year SCIT.
Efficacy by allergen — what the data shows
Cat SCIT and SLIT drops both have DBPC RCT evidence — unique among pet allergens. The SCIT RCT base yields ~72% symptom reduction; the SLIT RCT base yields 59%. The choice between them is primarily about whether the patient can sustain the clinic-visit burden of conventional SCIT.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
The central comparison for human cat allergy is the route of the same immunotherapy: conventional SCIT (~72%) traditionally meant ~100 clinic visits, while Curex now delivers that SCIT as a self-administered weekly shot at home. Sublingual drops (59%, daily) remain a needle-free modality. All are disease-modifying; the practical difference is how the immunotherapy is delivered.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Cat SCIT for Humans (Curex) | |||||
Cat SLIT Drops for Humans (needle-free modality) | |||||
Antihistamines + Nasal Steroids |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
Curex delivers the at-home cat allergy shot kit (SCIT) for $129/month all-inclusive — the same FDA-standardized-extract immunotherapy in the clinical evidence, given as one weekly shot at home instead of the roughly 95 to 119 in-clinic visits a 3-to-5-year conventional course requires per Cox 2011. The personalized serum is sterile-compounded to USP <797>, a board-certified allergist oversees the plan, your first dose and every dose change are supervised live over Zoom, and a prescribed epinephrine auto-injector is confirmed on hand.
See if at-home shots are right for youSide effects — what to watch for
Human cat SCIT has the same safety profile as all SCIT. SLIT drops have a substantially milder profile with no confirmed fatalities. For conventional SCIT, the mandatory 30-minute observation period is the key safety control.
Insurance coverage — what to expect
Human cat SCIT is covered by major commercial insurers and Medicare Part B when standard medical necessity criteria are met. For full details, see /allergy-shots/cost/does-insurance-cover-allergy-shots.
Skip the insurance hassle — Curex is $129/mo flat, no insurance needed.
Start free assessmentFrequently asked questions
Why are there so many cat allergy shots involved — why not just one?
Allergy immunotherapy requires repeated exposure to the allergen over years to achieve durable immune tolerance. Unlike a vaccine for an infection (which confers immunity in one or a few doses), allergen immunotherapy must gradually retrain an overactive IgE response — building IgG4 blocking antibodies, expanding regulatory T cells, and reducing Th2 cytokines — through sustained exposure. The Cox 2011 AAAAI/ACAAI Practice Parameter requires a minimum of 3 years of maintenance (after the ~26-week build-up) because shorter courses produce shorter-lasting benefit. This reflects the biology of immune remodeling, not an arbitrary schedule. At-home SCIT through Curex delivers that same multi-year course as a self-administered weekly shot rather than weekly clinic trips, with the first dose and every dose change supervised live over Zoom.
Why do nearly one in four people stop cat allergy shots?
Tkacz JP et al. (Curr Med Res Opin 2021;37[6]:957–965; IBM MarketScan 2014–2017, n=103,207) found 23.9% of allergen-immunotherapy patients never returned after the first injection consultation, and only 43.9% ever reached maintenance. The primary driver is visit burden: conventional SCIT requires approximately 39 in-clinic visits in Year 1 and 14–20 visits/year in maintenance years. Each visit includes a 30-minute post-injection observation period, creating scheduling, travel, and time-off-work demands that accumulate over 3–5 years. This is a structural access problem, not a motivation problem. At-home SCIT through Curex addresses it directly: after an allergist confirms candidacy, eligible maintenance patients give one weekly shot at home, with the first dose and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand.
Is cat SLIT as effective as cat SCIT for humans?
Cat SLIT drops and cat SCIT have different but both evidence-backed efficacy levels. Cat SCIT yields approximately 72% symptom reduction in DBPC RCTs (Varney 1997 Clin Exp Allergy). Cat SLIT drops yield 59% symptom reduction vs placebo in a DBPC RCT (Alvarez-Cuesta E et al., Allergy 2007;62:810–817). The gap is approximately 13 percentage points, which should be weighed against the difference of approximately 95–119 clinic visits (SCIT) versus daily home drops (SLIT) over a 3-to-5-year course. For patients where the visit burden of SCIT is the expected barrier to completion, the 59% SLIT efficacy may be clinically preferable to the theoretical 72% SCIT efficacy that 23.9% of patients never reach in practice.
Do you need to get cat allergy shots forever?
No. A complete 3-to-5-year course of cat immunotherapy is intended to produce durable disease modification that persists after stopping treatment. Durham SR et al. (NEJM 1999;341:468–475) demonstrated at least 4 years of sustained remission following a 3-year SCIT course. The estimated post-treatment benefit for a complete course is 7–12 years. This disease-modifying durability is the fundamental difference between immunotherapy (limited course, lasting benefit) and pharmacotherapy (indefinite daily medication, no modification of the underlying allergy). Patients who complete the full recommended course are generally advised they do not need to continue injections indefinitely.
What if I am also allergic to dog and cat — can I get both shots?
Yes. A board-certified allergist can formulate a multi-allergen SCIT vial containing both cat and dog extract components. However, the addition of dog extract to a cat SCIT regimen introduces the evidence caveats specific to dog: dog extracts are not FDA-standardized (unlike cat-hair and cat-pelt at 10,000 BAU/mL, Greer license #308), and the 2016 Ann Allergy Asthma Immunol systematic review (Smith DM, Coop CA) rated dog SCIT evidence as 'poor and conflicting.' Component-resolved testing for Can f 1 vs Can f 5 for dog (in addition to Fel d 1 for cat) should precede any multi-allergen immunotherapy plan to determine whether dog exposure is Can f 5-monosensitized (in which case adopting a female dog eliminates the exposure without immunotherapy) or Can f 1-driven.
Are cat allergy shots covered by insurance for humans?
Yes. Human cat SCIT is covered by all major US commercial insurers and Medicare Part B when standard medical necessity criteria are met: documented IgE-mediated sensitization to cat dander, symptoms occurring with cat exposure, and inadequate response to avoidance and pharmacotherapy. UnitedHealthcare ended coverage of home-administered SCIT effective January 1, 2023 — in-office administration with a 30-minute observation period is required for coverage. The CMS 2025 PFS allowed amount for CPT 95117 (two or more injections) is approximately $11.97 per visit. For detailed insurer-by-insurer coverage, see /allergy-shots/cost/does-insurance-cover-allergy-shots.
Related Articles
Allergy Shot Name: SCIT Defined & Explained | Curex
The clinical name for an allergy shot is subcutaneous immunotherapy (SCIT). There is no single brand name — each vial is custom-compounded. SLIT tablets have brand names; SCIT does not.
Read moreCat Allergy Vaccine Explained | Curex SCIT Guide
Cat allergy vaccine means three different things. SCIT uses FDA-standardized Fel d 1 extract for ~72% symptom relief. No one-shot cure exists.
Read moreAllergy Shots for Cat Allergy | Full SCIT Guide | Curex
Allergy shots for cat allergies reduce symptoms 60-72% at the 15 mcg Fel d 1 maintenance dose. Cat SCIT efficacy, dosing, and alternatives.
Read moreTypes of Allergy Injections: Full Guide | Curex
Types of allergy injections include SCIT (immunotherapy), biologics like Xolair and Dupixent, depot steroids, and epinephrine. Only SCIT modifies the underlying disease.
Read moreAllergy Shots for Cats (Humans) | Curex SCIT Guide
Allergy shots for cats target Fel d 1 for HUMANS, not the pet. 23.9% quit conventional SCIT (Tkacz 2021). Curex delivers that SCIT at home, $129/mo.
Read moreCat Allergy Shots for Humans | Curex SCIT Guide
Cat allergy shots use FDA-standardized Fel d 1 extract for ~72% symptom relief. RCT evidence, schedule, plus at-home SCIT from Curex at $129/mo.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.